Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
Izorlisib by Stemline Therapeutics for Metastatic Colorectal Cancer: Likelihood of Approval
Izorlisib is under clinical development by Stemline Therapeutics and currently in Phase II for Metastatic Colorectal Cancer. According to GlobalData,...
Data Insights
Izorlisib by Stemline Therapeutics for Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer (HER2- Breast Cancer): Likelihood of Approval
Izorlisib is under clinical development by Stemline Therapeutics and currently in Phase II for Human Epidermal Growth Factor Receptor 2...